The role of tumor‐secreted galectin‐9 in CD8+ T cell exhaustion was further validated using PBMC activated by CD3/CD28 and conditioned medium collected from galectin‐9‐manipulated cell lines. The gene discussed is CD8A; the disease is neoplasm.